Laparoscopic Diagnosis of Adenomyosis : a Case Report by Fujishita Akira et al.
Acta Med. Nagasaki 42 : 51-53
Laparoscopic Diagnosis of Adenomyosis : a Case Report
Akira FUJISHITA, Hideaki MASUZAKI, Raul ORTEGA CHAVEZ, 
Hisayoshi NAKAJIMA, Tadayuki ISHIMARU
Department of Obstetrics and Gynecology, Nagasaki University School of Medicine
 Usually, Adenomyosis is diagnosed after surgery. Lapa-
roscopic diagnosis may have advantages over other surgical 
procedures, especially for infertility patients undergoing 
expectant therapy. We successfully diagnosed adenomyosis 
using a laparoscopic needle biopsy technique in an infertility 
patient.
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Introduction 
 Adenomyosis is the invasion and growth of normal 
endometrium in the myometrium. It is characterized by 
enlargement of the uterus, dysmenorrhea and menorrhagia 
and often occurs in the patient's fifties. Traditionally, 
total hysterectomy has been the treatment of choice. 
However, women who want to remain fertile often request 
an alternative treatment for adenomyosis, such as Gona-
dotropin-releasing hormone agonist (GnRH-a) therapy. 
 Most cases of adenomyosis are diagnosed from a re-
moved uterus. There are only four cases of conservative 
treatment in which a definitive diagnosis of adenomyosis 
was established histologically1-4). Laparotomy was per-
formed in all previous cases, but the present case was 
successfully diagnosed using laparoscopic needle biopsy. 
To the best of our knowledge, this is the first case report 
of adenomyosis confirmed by laparoscopical needle biopsy.
Case Report 
 A 30-year-old woman was seen for evaluation of secon-
dary infertility. A past pregnancy ended in artificial 
abortion when she was 20 years old. Menstruation began at 
age 11. She complained of severe dysmenorrhea and moder-
ate dyspareunia. Pelvic examination revealed a retroverted 
uterus that was regular in contour but swollen to approxi-
mately 11 weeks' gestational size. Transvaginal ultra-
sound revealed thickening of the myometrium and diffuse 
foci distributed throughout the myometrium. 
 Investigation of the patient's infertility began in 1991 at
a private hospital. The results of hysterosalpingography 
suggested deformity of the uterine cavity and left tubal 
occlusion. The right tubal patency was normal. GnRH-a 
was administered from September 1991 to March 1992 for 
clinically suspected endometriosis. The patient was re-
ferred to our hospital in August 1994 for further examina-
tion and adjuvant therapy. An infertility screening test 
was conducted, but there were no abnormal findings other 
than an enlarged uterus and elevated tumor marker levels. 
MR images suggested diffuse adenomyosis involving the 
entire uterine myometrium (Figure 1). The abnormal 
tumor marker levels indicated CA-125 in the luteal phase : 
77 U/ml (cutoff < 35 U/ml). 
 In September 1994, a laparoscopic study revealed stage 
lI endometriosis (r-AFS score (1985) : 2 points), and 
adenomyosis was suspected because the uterus was swollen 
to 12 weeks' gestational size, and there were deep lesions in 
the subserosal myometrium. Blue berry spots were also 
seen in the vesico-uterine peritoneum (Figure 2). A needle 
biopsy was taken from the uterine myometrium. Vas-
opressin (Pitressin injection ; Sankyo Co. Ltd., Tokyo, 
Japan) was dissolved in 4 ml of saline solution and in-
jected in the sub-serosa of the uterus. Then a biopsy was 
taken with a single needle puncture instrument (SR-26178 
DH ; Karl Storz Co. Ltd., Germany) from the uterine 
myometrium through the sub-serosa. The biopsy revealed 
endometrial glands and stroma tissue within the 
myometrium, confirming the diagnosis of adenomyosis 
(Figure 3). 
 Despite the severe symptoms, complication of mild 
endometriosis and adenomyosis, because of the patient's 
wish to remain fertile, we decided to avoid hysterectomy. 
The treatment selected was expectant therapy, i.e., electro-
cautery of the endometriotic implants, laparoscopic 
uterosacral nerve ablation and irrigation of the peritoneal 
cavity. Two months after expectant therapy, the patient 
conceived without medical treatment. Unfortunately, a 
spontaneous abortion occurred after 18 weeks of gestation.
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Figure 1 Sagittal T-2 weighted MR image (SE 600/30) of the 
pelvis shows the uterus markedly enlarged and high intensity 
spots in the myometrium. The junctional zone in both 
sections is unclear. (a) SE 600/30 and (b) SE 2,000/80.
Figure 3 Endometrial glands and stroma tissue within the 
myometrium. The arrowhead shows the uterine serosa. (H & 
E, final magnification, X33)
Figure 2 (a) Adenomyosis in a uterus as seen through 
laparoscopy and (b) blue berry spot (arrow) in the pelvic 
peritoneum.
Discussion 
 Hysterectomy is usually the therapy of choice for 
adenomyosis. Recently, preoperative diagnosis of adeno-
myosis is made by vaginal ultrasound or laparoscopic 
surgery') . Percutaneous or transcervical myometrial 
biopsy is a possible alternative for patients with ade-
nomyosis, especially those who wish to remain fertile. 
However, according to another report, sensitivity is low 
and diagnosis rate depends on the number of biopsies and 
the depth of adenomyosis'). Improvements in myometrial 
biopsy will undoubtedly lead to a standard method of 
treatment. Our successful diagnosis of adenomyosis by 
needle biopsy may be attributable to our having coinciden-
tal observed endometrial foci in the subserosal myo-
metrium. 
 Nowadays, various ultrasonographic and radiological 
studies are being described for the diagnosis of ade-
nomyosis. Bohlman et al'). suggested that ultrasound may 
aid diagnosis by showing that a uterus is moderately 
enlarged and has an anechoic, thickened posterior portion. 
Fedele et a18>. also reported that diagnostic capability can
be enhanced by transvaginal ultrasonography. The sensi-
tivity of transvaginal ultrasound findings was 80%, and 
the specificity was 74%, showing that ultrasound was a 
quick, non-invasive and useful method for the diagnosis of 
diffuse adenomyosis. Mark et al9). studied 21 patients with 
clinically suspected adenomyosis using MRI and correctly 
predicted all eight cases in which the disease was con-
firmed histologically. Togashi et al'). also performed a 
prospective study to evaluate the ability of MRI to 
differentiate between adenomyosis and uterine myoma. 
MRI accurately diagnosed the cause of uterine enlargement 
in 92 of 93 cases. Only one diagnosis of adenomyosis was 
mistaken. However, microscopic studies failed to explain 
the definitive difference in intensity between areas of 
adenomyosis and myometrium. Our case revealed typical 
adenomyosis findings by MRI and diffuse adenomyosis by 
ultrasonography, then confirmed the diagnosis using a 
laparoscopic needle biopsy taken from the uterine myo-
metrium. 
 Adenomyosis is often accompanied by additional pelvic 
pathology such as uterine leiomyoma. It also occurs 
concomitantly in 6-20% of patients with endometriosis'". 
Our case of adenomyosis was also complicated with pelvic 
endometriosis. GnRH-a therapy has demonstrated efficacy 
in reducing the size of uterine fibroid and in suppressing 
the extent and activity of endometriotic implants. There 
are four other reported cases of successful treatment of 
the symptoms of severe adenomyosis with GnRH-a14> 
GnRH-a therapy was successfully used to produce a 
hypoestrogenic environment in endometriosis and uterine 
myoma. However, there were side effects, such as abnor-
mal lipid metabolism, bone loss, and certain symptoms in 
the hypoestrogenic state. Our patient had previously 
received GnRH-a therapy and had complained of hot 
flashes and moderate headache. Fedele et al"). reported 
that there was no marked difference between GnRH-a 
therapy and expectant management in the treatment of 
infertility patients with minimal or mild endometriosis. In 
view of the possible side effects and the patient's refusal 
of GnRH-a therapy, we decided upon expectant manage-
ment. It is still unclear how fertility is promoted by 
GnRH-a therapy, but our patient conceived two months 
later without medical treatment. 
 Only three cases of pregnancy confirmed after GnRH-a 
treatment of adenomyosis have been reported, with one 
pregnancy ending in a spontaneous abortion after 10 weeks 
of gestation'). Another report described an early viable
pregnancy, but the outcome of the pregnancy was not 
published'). Only one case was a normal delivery'). Another 
patient did not conceiver. Our patient conceived soon after 
laparoscopic treatment, but spontaneous abortion oc-
curred after 18 weeks of gestation. The relationship 
between the patient's spontaneous abortion and ade-
nomyosis is unknown. Further studies are needed to 
determine the. pathogenic mechanism of infertility in 
women with adenomyosis. Whether the adenomyosis 
treatment selected is GnRH-a therapy, reduction surgery 
or expectant therapy, the physician must take into account 
the uterine size, fertility period and other factors of 
infertility. 
 Finally, in accordance with the trend toward minimally 
invasive surgery, laparoscopy is gaining importance in 
gynecologic surgery. A laparoscopic approach for the 
diagnosis of adenomyosis may have advantages over other 
surgical procedures. Because this is the first case of 
adenomyosis diagnosed by laparoscopic needle biopsy 
technique, we recommend further studies to develop a 
standard a pre-operative diagnosis of the disease.
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